About Event

With 35+ hours of content, 4 interactive workshops and over 7 hours of virtual networking with key industry leaders, this comprehensive forum uniquely combines distinct inflammasome researchers in one setting to share lessons learned, case studies and advancements in the field.

With an emphasis on targeting the inflammasome to develop clinically effective therapeutics, this one-of-a-kind, discussion-led summit will enable you to deepen your understanding of novel inflammasome pathways focusing not only on NLRP3 but looking beyond and outside of this exciting pathway.

top reasons to attend
attending Companies Inlafm
seniority Inflam

2020 Confirmed Attendees Included:

Inflammasome companies attending